TCM
GBT

Tekla Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Tekla Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-71,759
Closed -$3.96M – 211
2020
Q3 		$3.96M Hold
71,759
– – 0.15% 114
2020
Q2 		$4.53M Sell
71,759
-46,324
-39% -$3.18M 0.17% 108
2020
Q1 		$6.03M Sell
118,083
-29,085
-20% -$1.95M 0.27% 72
2019
Q4 		$11.7M Buy
147,168
+54,211
+58% +$3.21M 0.44% 50
2019
Q3 		$4.51M Buy
92,957
+25,441
+38% +$1.33M 0.2% 87
2019
Q2 		$3.55M Sell
67,516
-18,472
-21% -$1.06M 0.14% 109
2019
Q1 		$4.55M Sell
85,988
-7,936
-8% -$390K 0.18% 99
2018
Q4 		$3.86M Sell
93,924
-38,346
-29% -$1.44M 0.17% 98
2018
Q3 		$5.03M Buy
132,270
+72,880
+123% +$3.23M 0.18% 92
2018
Q2 		$2.68M Sell
59,390
-70,558
-54% -$3.21M 0.1% 123
2018
Q1 		$6.28M Hold
129,948
– – 0.24% 85
2017
Q4 		$5.11M Buy
129,948
+67,448
+108% +$2.52M 0.2% 91
2017
Q3 		$1.94M Sell
62,500
-62,500
-50% -$1.76M 0.07% 121
2017
Q2 		$3.42M Sell
125,000
-47,500
-28% -$1.41M 0.13% 94
2017
Q1 		$6.36M Sell
172,500
-208,800
-55% -$5.26M 0.25% 74
2016
Q4 		$5.51M Buy
381,300
+256,300
+205% +$4.5M 0.23% 75
2016
Q3 		$2.88M Hold
125,000
– – 0.11% 105
2016
Q2 		$2.07M Buy
+125,000
New +$2.52M 0.08% 130

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tekla Capital Management's GBT Position: Q4 2020 in Review

Tekla Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 71,759 shares — an estimated $3.96M sold.

Tekla Capital Management first reported a position in GBT in Q2 2016 and held it in 18 quarters. The position peaked at $11.7M in Q4 2019. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

  • Tekla Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Tekla Capital Management sold 71,759 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $3.96M.
  • Tekla Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 18 quarters.
  • Tekla Capital Management's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q4 2019.
  • 228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Tekla Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.